Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Clinical CEST MR Fingerprinting Method for Treatment Response Assessment in Brain Metastases

NCT05559853 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT05559853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05559853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Clinical CEST MR Fingerprinting Method for Treatment Response Assessment in Brain Metastases
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
September 22, 2022
Completion date
September 22, 2027
Enrollment
119 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, brain metastases, adult, metastatic brain cancer, metastatic brain tumor